Therefore, members of the Trx superfamily of proteins, the Trx-Prx system, could constitute promising biomarker candidates for the early diagnosis of AD, reflecting their crucial involvement in the treatment and pathogenesis of the disease. Here, TXN is linked to Alzheimer disease.